The OHSU Vaccine and Gene Therapy Institute, West Campus in Beaverton, OR is a renowned research facility dedicated to advancing the fields of vaccine development and gene therapy. With a team of esteemed faculty and a robust graduate program, the institute conducts cutting-edge research and publishes numerous publications in these areas. While not a clinical institute for receiving vaccines, the VGTI plays a crucial role in vaccine studies and COVID-19 developments, earning grants and awards for its contributions. The West Campus is a closed facility, accessible only by invitation, and offers videoconferencing capabilities for collaboration and communication. OHSU Vaccine and Gene Therapy Institute is committed to improving the health and quality of life for Oregonians through excellence, innovation, and leadership in healthcare, education, and research. As an equal opportunity affirmative action institution, OHSU fosters diversity and inclusion in its operations. With a dedicated administrative director and building and equipment manager, the institute ensures efficient operations and maintains state-of-the-art facilities. OHSU's mission is to make significant contributions to the field of medicine and healthcare, and its commitment to integrity and patient care is evident in its comprehensive resources and services.Generated from the website